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Among several quantitative invariants found in evolutionary genomics, one of the most striking
is the scaling of the overall abundance of proteins, or protein domains, sharing a specific functional
annotation across genomes of given size. The size of these functional categories change, on average,
as power-laws in the total number of protein-coding genes. Here, we show that such regularities are
not restricted to the overall behavior of high-level functional categories, but also exist systematically
at the level of single evolutionary families of protein domains. Specifically, the number of proteins
within each family follows family-specific scaling laws with genome size. Functionally similar sets
of families tend to follow similar scaling laws, but this is not always the case. To understand this
systematically, we provide a comprehensive classification of families based on their scaling properties.
Additionally, we develop a quantitative score for the heterogeneity of the scaling of families belonging
to a given category or predefined group. Under the common reasonable assumption that selection is
driven solely or mainly by biological function, these findings point to fine-tuned and interdependent
functional roles of specific protein domains, beyond our current functional annotations. This analysis
provides a deeper view on the links between evolutionary expansion of protein families and the
functional constraints shaping the gene repertoire of bacterial genomes.
ar
X
iv
:1
70
3.
09
82
2v
1 
 [q
-b
io.
GN
]  
28
 M
ar 
20
17
2I. INTRODUCTION
As demonstrated by van Nimwegen [1] and confirmed by a series of follow-up studies [2–6], striking quantitative
laws exist for high-level functional categories of genes. Specifically, the number of genes within individual functional
categories such as e.g. that of transcriptional regulators [1, 7, 8] exhibit clear power-laws, when plotted as a function
of genome size measured in terms of its number of protein-coding genes or, at a finer level of resolution, of their con-
stitutive domains. In prokaryotes, such scaling laws appear well conserved across clades and lifestyles [9], supporting
the simple hypothesis that these scaling laws are universally shared by this group.
From the evolutionary genomics viewpoint [10], these laws have been explained as a byproduct of specific “evolu-
tionary potentials”, i.e., per-category-member rates of additions/deletions fixed in the population over evolution. As
predicted by quantitative arguments, estimates of such rates correlate well with the category scaling exponents [1, 2].
A complementary point of view [5, 8, 11] focuses on the existence of universal “recipes” determining ratios of pro-
teins between different functions. Such recipes should mirror the “dependency structure” or network operating within
genomes as well as other complex systems [12]. According to this point of view the usefulness, and thus the occurence,
of a given functional component depends on the presence of a set of other components, which are necessary for it to
be operational.
Beyond functional categories, protein coding genes can be classified in “evolutionary families” defined by the
homology of their sequences. Functional categories routinely contain genes from tens or more of distinct evolutionary
families. The statistics of gene families also exhibits quantitative laws and regularities starting from a universal
distribution of their per-genome abundance [13], explained by evolutionary models accounting for birth, death, and
expansion of individual families [14–16].
While some earlier work connects per-genome abundance statistics of families with functional scaling laws [5], the
link between functional category scaling and evolutionary expansion of gene families that build them remains relatively
unexplored. Clearly, selective pressure is driven by functional constraints, and thus selection cannot in principle
recognize families with identical functional roles. On the other hand, slight differences in the functional spectrum of
different protein domains, and interdependency of different functions can make the scenario more complex. Thus, one
central question is how the abundance of genes performing a specific function emerges from the evolutionary dynamics
at the family level.
Two alternative extreme scenarios can be put forward: (i) the high-level scaling laws could emerge only at the
level of functions, and be “combinatorially neutral” at the level of the evolutionary families building up a particular
function, or, vice versa, (ii) they could be the result of the sum family-specific scaling laws. In the first scenario all
or most of the families performing a particular function would be mutually interchangeable. In the second scenario,
the evolutionary potentials would be family-specific and coincide with family evolutionary expansion rates, possibly
emerging from the complex dependency structure cited above, and from fine-tuned functional specificity of distinct
families. An intermediate possibility is that an interplay of constraints acts on both functional and evolutionary
families. The first test for the feasibility of the second scenario is the existence of scaling laws for individual families.
Here, focusing on bacteria, and using protein domains to define families, we present a clear evidence for family-specific
scaling laws with genome size. We show that the abundance of the families follows power laws with genome size.
Comparing functional categories with a suitable null model, we show that family-specific exponents may deviate
significantly from the exponent of the associated functional category. We provide a comprehensive classification of
families based on common scaling exponents, which recovers the known functional associations as well as revealing
new ones, and may be used to detect possible misannotations. Finally, we develop quantitative tools to measure the
heterogeneity of the scaling of families belonging to a given category or predefined group of families.
II. MATERIALS AND METHODS
Data sources
We considered bacterial proteomes retrieved from the SUPERFAMILY (release 1.75 downloaded in October
2014, [17]) and PFAM (release 27.0 downloaded in October 2014, [18, 19]) database. Evolutionary families
were defined from the domain assignments of 1535 superfamilies (SUPERFAMILY database) and 446 clans (PFAM
3database) on all protein sequences in completed genomes. We focused the analysis on the 1112 bacterial proteomes
used as species reference in the SUPERFAMILY database. For the functional annotations of the SUPERFAMILY
data, we considered annotation of SCOP domains as a scheme of 50 more detailed functional categories, mapped to
7 more general function categories, developed by C. Vogel [20]. PFAM clans were annotated on the same scheme
of 50 functional categories, using the mapping of clans into superfamilies available from the PFAM website http:
//pfam.xfam.org/clan/browse#numbers [21].
Data analysis
For each evolutionary domain family (or a functional category consisting of multiple evolutionary families), genome
sizes (measured in the overall number of domains) were logarithmically binned. For each bin we calculated mean
and standard deviation of the given family abundance (number of domains) within the bin. The estimated scaling
exponent βi for family i is the result of the non-linear least squares fitting of the binned data weighted by the standard
error of family abundance. Genome size bins containing less than 10 genomes were not taken into account. To filter
out the data that, due to low-abundance or rare families, were affected by sampling problems, we considered three
independent parameters, (i) the “occurrence”, i.e. the fraction of genomes where family i is present, oi = N
(i)
G /NG,
where NG is the total number of genomes in the sample, and N
(i)
G is the number of genomes where the family has
non-zero abundance, (ii) the goodness of fit index
si =
1
1 +
√
LSi
where LSi is the error associated with the exponent βi, measured as the average squared deviation between the fit
and the logarithm of the empirical abundance (see SI sec. S1), and (iii) the Pearson correlation coefficient ρi between
the logarithm of the family abundance and the logarithm of the genome size. The index si puts on the same ground
families with different exponents, but generally decreases as the scaling exponent increases, in accordance with the
growth of fluctuations in families with higher exponents observed in ref. [22]. Hence, we decided to use it only for low
exponents, where the Pearson correlation is a bad proxy of scaling. We considered families with si > 0.9 and oi > 0.6
for exponents lower than 0.2, otherwise families with ρi > 0.4 and oi > 0.6 reducing the dataset to 357 superfamilies
and 178 clans that satisfy both requirements. As shown in Fig. S1A, si and oi are not mutually correlated across the
genomes, implying that the two requirements are in fact independent, the same is valid for ρi and oi, see Fig. S1B.
We verified that the removed families with the procedure described above do not influence the scaling of the category.
Supplementary Fig. S2 reports the exponent of the category scaling before the thresholding (where all the families
are considered) and after (where the domains belonging to the removed families are not considered in the category
scaling), showing that the values are consistent for all the categories studied.
For each family within a given functional category, we defined a “heterogeneity score” hi as follows:
hi = |βc − βi|,
where βi and βc are,respectively, the scaling exponents of family i and functional category c. The heterogeneity
measure for each functional category was defined as the average of the per-family heterogeneity scores hi:
Hc =
1
Fc
∑
i
hi,
where Fc is the number of families in category c.
The significance of the values found with this formula was assessed against a null model assuming that the total
abundance of a category is distributed randomly across the associated families. The average abundance (i.e. the
fraction of domains belonging to a family averaged over genomes) and occurrence (fraction of genomes where the
family is present) of each family are both conserved (note that these two properties are uncorrelated in the data,
hence we chose to conserve both in the null model, assuming that they are independent, see Supplementary Fig. S3).
Given a genome g with ngc elements in the functional category c, divided into F
g
c associated families, we redistributed
the ngc members among the F
g
c sets conserving the average relative abundance of each family (see SI sec. S2). A
4member of family i belonging to category c was therefore added with probability
pi,c ∝

1
N
(i)
g
N
(i)
G∑
g′=1
ng
′
i∑
k∈c n
g′
k
, if ngi 6= 0
0 , if ngi = 0 .
The resulting set of Fc artificially built evolutionary categories constrains the occurrence pattern and the average
abundance of the original ones. Scaling exponents for families in the null model are extracted with the procedure
described above. Only functional categories containing domains from more than 10 distinct families were compared
to the null model. All procedures were implemented as custom Python 2.7 scripts.
III. RESULTS
Families have individual scaling exponents, reflected by family-specific scaling laws
We started by addressing the question of whether individual families show scaling laws, and thus can be associated
to specific scaling exponents. In order to do so, we isolated domains belonging to the same family across the sample
of 1112 species-representative bacterial proteomes and plotted their abundance against the total number of domains
in the corresponding proteome.
When the abundance is sufficiently high to overcome sampling problems, most families show a clearly identifiable
individual scaling when plotted as a function of genome size. As an example, Fig. 1 shows the scaling of a set of
chosen families in four selected functional categories. Additionally, some low-abundance families that occur in all
genomes with a very consistent number of copies show definite scaling with exponents close to zero [22], being clearly
constant with size, with little or no fluctuations.
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FIG. 1. Families follow specific scaling laws, which may agree or deviate from the overall scaling of the functional category to
which this family belongs. The plots report the abundance of twelve different superfamilies as a function of the genome size
(triangles are binned averages). The power-law fits (colored lines) are compared to the power-law fits of the functional category
to which each family belong (dashed black lines). We display here examples from four functional categories: DNA binding (top
row), Translation (second row from top), Transferases (third row from top) and Protein modification (bottom row). Families in
the leftmost / rightmost column scale respectively slower/faster than their category means, families in the middle column have
similar slope to the full category. Legends specify the SCOP superfamily id, family descriptive name and power-law exponent
(βi) from the fits.
Given that functional categories follow specific scaling laws, likely related to function-specific evolutionary trends [1,
2], there remain different open possibilities for the behavior of the evolutionary families composing the functional
5categories. One simple scenario is that family scalings are family-specific, thus validating the existence of family
evolutionary expansion rates that are quantitatively different to the one of their functional category. In the oppo-
site extreme scenario the scaling is only function-specific, and individual families performing similar functions are
interchangeable. If this were the case, family diversity in scaling exponent would be only due to sampling effects,
and the null model would fully reproduce the diversity in family scaling observed in empirical data. To address this
question, we randomized the families within a category conserving their occurrence patterns and the category average
abundance. The randomized families always show very similar scaling as the one of the corresponding category (see
Supplementary Fig. S4). Hence, this analysis strongly supports the existence of family-specific scaling exponents that
do not simply descend from the category scaling.
Fig. 1 shows that the presence of “outlier families” is common among functional categories. In most categories,
we found families where the deviations from the category exponents is clear, beyond the uncertainty due to the
errors from the fits. Fig. 1 shows some examples where in each of the shown categories βi may be higher, lower or
comparable to βc. A table containing all the family and category exponents is available as supplementary information
(Supplementary Table S1 and Table S2).
Finally, we considered the correlation of family scaling exponents with relevant biological and evolutionary pa-
rameters such as foldability (quantified by size-corrected contact order, SMCO [23]), the diversity of EC-numbers
associated with families (quantifying the functional plasticity of a given family), selective pressure (quantified by the
ratio of nonsynonimous to synonymous Ka/Ks substitution rates [24]) and overall family abundance. The results
are summarized in Supplementary Table S2. Foldability and Ka/Ks appear to have little correlation with scaling
exponents. Instead, we found a significant positive correlation of exponents with family abundance, and both quan-
tities are correlated with diversity of EC-numbers in metabolic families. This suggests that, at least for metabolism,
functional properties of a fold play a role in family scaling, and that beyond metabolism, abundance and scaling are,
on average, not unrelated.
The heterogenetiy in scaling exponents is function-specific.
The analyses presented above support the hypothesis that functional categories contain families with specific scaling
exponents. Indeed, the scaling exponents βi of the families can be significantly different from the category exponent
βc with deviations that are much larger than predicted by randomizing the categories according to the null model
(see Supplementary Fig. S4).
In order to quantify this “scaling heterogeneity” of functional categories, we computed for each family i the distance
between its scaling exponent βi and the category exponent βc (see Methods). We defined an index Hc quantifying the
heterogeneity of the scaling of the families within a category by averaging this distance over the families associated
to a given category c.
Figure 2A shows the relation between the heterogeneity Hc and the category exponent βc. Interestingly, these
two quantities are correlated, with categories with larger values of βc being more heterogeneous. This result can be
intuitively rationalized in terms of the degrees of freedom imposed by the category exponent to the scaling of single
families. Categories with small exponents are incompatible with extremely large fluctuations of family exponents,
while categories with larger exponents can contain families with small βi. Indeed, this trend of heterogeneity with
exponents is also observed in the null model, where the hetereogenity of null categories is much smaller than empirical
ones, since all families tend to take the exponent category (Supplementary Fig. S4).
Figure 2B allows a direct comparison of the heterogeneity of different categories by subtracting the mean trend. It
is noteworthy that the Signal Transduction functional category, which also has clear superlinear scaling, has much
lower heterogeneity than DNA-binding/transcription factors. Among the categories with linear scaling, Transferases
is one of the least heterogeneous ones, while the categories Protein Modification and Ion metabolism and Transport
show a large variability in the exponents of the associated families. For Protein Modification, this signal is essentially
due to the Gro-ES superfamily and to the HFSP90 ATP-ase domain, which have a clear superlinear scaling, while
other chaperone families, such as FKBP, HSP20-like and J-domain are clearly sublinear with exponents close to zero.
Interestingly, the Gro-EL domains, functionally associated to the Gro-EL, are part of this second class (exponent
close to 0.2), showing very different abundance scaling to the Gro-EL partner domains. Conversely, the category Ion
Metabolism and Transport is divided equally into linearly scaling (e.g., Ferritin-like Iron homeostasis domains) and
markedly sublinear families, such as SUF (sulphur assimilation) / NIF (nitrogen fixation) domains. On the other hand,
categories with small values of heterogeneity are made of families with exponents close to the one of the category, as
shown in Table I in the case of, e.g., Transferases.
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FIG. 2. (A) Functional categories with faster scaling laws contain families with more heterogeneous scaling exponents.
Heterogeneity is quantified by the mean deviation between the family scaling exponents and the category exponent. The plot
reports heterogeneity scores for different functional categories, plotted as a function of the category exponents. The black line is
the linear fit between heterogeneity and exponets (slope 0.3, intercept 0.1). (B) Comparison of heterogeneities subracted from
the linear trend. By this comparison, the least heterogeneous categories are Signal Transduction (T) and Transferase (RB),
and the most heterogenous are DNA Binding (LA) and protein modification (O). Translation (J) is slightly above the trend
for its low exponent. The legend (right panel) shows the association between symbols and category codes (see Supplementary
Table S1 for the corresponding category name).
Determinants of the scaling exponent of a functional category
We have shown that scaling exponents of individual families may correspond to a vsriable extent to the exponent
of the corresponding functional category. However, since categories are groups of families, the scaling of the former
cannot be independent of the scaling of the latter. This section explores systematically the connection between the
two. As detailed below, we find that in some cases the scaling exponent of functional categories is determined by
few outlier families, while in other cases most of the families within a category contribute to the category scaling
exponent.
While many families have a clear power-law scaling, functional categories may contain many low-abundance families
with unclear scaling properties. When considered individually, these families do not contribute much to the total
number of domains of a category, but their joined effect on the scaling of the category could be potentially important.
Supplementary Fig. S5 shows that the sum of these low-abundance families does not suffer from sampling problems
and shows a clear scaling. Interestingly, the scaling exponents for these sums once again does not necessarily coincide
with the category exponents.
Figure 3A illustrates the systematic procedure that we used in order to understand how the scaling of categories
emerges from the scaling of the associated families. Families were ranked by total abundance across all genomes (from
the most to the least abundant) and removed one by one from the category. At each removal step in this procedure,
both the scaling exponent of the removed family and the exponent of the remainder of the category are considered.
In other words, the i-th step evaluates the exponent of the i-th ranking family (in order of overall abundance) and of
the set of families obtained by removing the i top-ranking families (with highest abundance) from the category. The
resulting exponents quantify the contribution of each family to the global category scaling, as well as the collective
contribution of all the families with increasingly lower overall abundance.
The results (Fig. 3B and Supplementary Fig. S6 and S7), show how the heterogeneity features described above
are related to family abundance. The collective behavior of low-abundance families may deviate sensibly from that
of the functional category and families follow scaling laws that sensibly deviate from the one of the corresponding
functional categories. One notable example of this are Transcription-Factor DNA-binding domains. If the abundance
of the outliers families is large enough in terms of the fraction of domains in the functional category, they might be
responsible for determining the scaling of the entire category, as it happens in the case of DNA-binding (which is
more extensively discussed in the following section).
Overall, one can distinguish between two main behaviors, either a category scaling is driven by a low number of
highly populated “outlier” families (e.g. DNA binding and Protein Modification in Fig. 3B), or the category scaling
is coherent, and robust to family subtraction (e.g. Transferases and Translation in Fig. 3B). While the first behavior
appears to be more common for functional categories with higher scaling exponent, there are some exceptions. Notably,
the scaling of strongly super-linear categories is not always driven by a few families. For example, the functional
category Signal Transduction has an exponent βc = 1.7, which remains stable after the removal of the largest families
(Supplementary Fig. S5 and S7). Both behaviors are clearly visible for intermediate exponents (in order to appreciate
this, compare the Transferases and Protein Modification categories in Fig. 3B).
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FIG. 3. Systematic removal of families (ranked by abundance) inside functional categories reveals how individual families build
up functional category scaling. (A) Illustration of the procedure. Families belonging to a given functional category are ranked
by overall abundance on all genomes and removed one by one from the most abundant. The scaling of the removed family and
the remainder of the category is evaluated after each removal. The plots are a stylized example of the first two steps (using
values for the category DNA binding). βc is the category exponent, βi are family exponents and βc\{i} are the stripped-category
exponents, computed after the removals. (B) Results of this analysis for four functional categories. Grey circles represent the
exponents βi (and their errors) for the scaling law of each family belonging to the functional category (in order of rank in total
abundance). Colored circles are the scaling exponents of functional categories without the domains of the i least abundant
families. The size of each symbol is proportional to the fraction of domains in the family or family-stripped category. Error bars
are uncertainties of the fits (see Methods). See Supplementary Fig. S6 and S8 for the same plots obtained for other functional
categories and using the PFAM database.
Super-linear scaling of transcription factors is determined by the behavior of a few specific highly populated
families.
We considered, in particular, the case of DNA-binding / transcription factors [6], which are known to exhibit
peculiar scaling in bacteria [8, 25]. The abundance of domains in this functional category increases superlinearly
(almost quadratically) with the total domain counts [1, 11, 22]. As shown in the first row of Fig. 1B, not all the
families in this functional category display a superlinear scaling [6], and the collective scaling of the low-abundance
families with genome size is much slower (see Fig. 3 and Supplementary Fig. S5). Fig. 3B shows that only the most
5-6 abundant families display a super-linear scaling (βi > 1). These are Winged helix DNA-binding domains (34.8%
of abundance), Homeodomain-like (23.3 %) lambda repressor-like DNA-binding domains (9.5%) bipartite Response
regulators (7.7%) Periplasmic binding protein-like (6.2%), and FadR-like (2.4%). The remaining 16.1% of the DNA-
binding regulatory domains follows a clear sublinear scaling with genome size (exponent 0.7, see Supplementary
Fig. S5).
8Grouping families with similar scaling exponents shows known associations with biological function and
reveals new ones.
The above analyses show that the range of scaling exponents of families within the same functional categories is
generally wide and that the scaling behavior of some families sensibly deviates from their category. At the same time,
functional categories show clear characteristic scaling laws, with well-defined exponents βc [9]. We, therefore, asked to
what extent a range of family scaling exponents βi is peculiar to a functional category and how this compares to the
category exponent βc. To this end, we grouped families based on their scaling exponents. We then used those groups
to test how much specific range of exponents define specific functions by an enrichment test of functional annotations.
Table I shows that in most cases functional categories are over-represented in the exponent range where their scaling
exponents βc is found. This confirms and puts in a wider perspective the previously reported strong association
between abundance scaling with size and functional annotation. As can be expected from previous results, the
functional category Protein Modification is an exception: this category is under-represented in the linear region even
though its category exponent is ∼ 1.06, since it contains two strongly superlinear families and a bulk of families with
sublinear scaling. This strong heterogeneity in scaling exponents is also visible in Fig. 3B.
The results of this analysis are not sensitive to the chosen intervals for the scaling exponents. In order to show
this, we performed a more systematic enrichment analysis, using sliding windows of exponents of width 0.4, and step
0.1, and plotting the Z-score for the enrichment as a function of the representative family exponent for each window
(Supplementary Fig. S9). The maxima of this plot define a representative exponent for each functional category,
and can be compared to the exponent βc measured directly from the plot of category abundance vs genome size (see
Supplementary Figure S10). Interestingly, this analysis also shows that in many cases a single functional category is
enriched for multiple groups of families with well-defined exponents, as in the case of the Protein Modification category.
The cases of Ion Metabolism and Transport (already discussed), Coenzyme Metabolism and Transport, Redox also
shows clear indications of enrichment for two or more exponent groups. For the category Coenzyme Metabolism and
Transport this is due to the presence of a single abundant family with scaling exponent close to 2, the acyl-CoA
dehydrogenase NM domain-like, whose functional annotation is still not well defined. In the case of Redox, the most
abundant families (Thioredoxin-like, 4Fe-4S ferredoxins, Metallo-hydrolase/Oxydoreductase) scale linearly, but there
is a wide range of families with exponents between 0.5 and 1, and once again two fairly abundant outlier families with
superlinear scaling (Glyoxalase/Bleomycin resistance protein/Dioxygenase, and ALDH-like), both with a fairly wide
range of functional annotations.
IV. DISCUSSION AND CONCLUSIONS
Our results gather a critical mass of evidence in the direction of family-specific expansion rules for the families of
protein domains found in a genome. Although previous work had focused on individual transcription factor families [6],
finding in some cases some definite scaling, no attempts were made to address this question systematically. The scaling
laws for domain families appear to be very robust, despite of the limited sampling of families compared to functional
annotations (which are super-aggregates of families and hence have by definition higher abundance). In particular,
the results are consistent between the different classifications of families we tested (SUPERFAMILY and PFAM, see
SI, sec. S4).
Overall, our results indicate that scaling laws are measurable at the family level, and, given the heterogeneous
scaling of families with the same functional annotations, families are likely a more reliable description level for the
scaling laws than functional annotations. The interpretation of these scaling laws is related to the evolutionary
dynamics of family expansion by horizontal transfer or gene duplication, and gene loss [1, 10, 26]. Scaling exponents
are seen as “evolutionary potentials” [2], is based on a model of function-specific (multiplicative) family expansion
rates. Assuming this interpretation, then our result that these rates may be different for different domain families
having the same functional annotation may seem puzzling. Clearly, selective pressure can only act at the functional
level, and if two folds were functionally identical, there should be reasonably no advantage selecting one with respect
to the other, and doing so at different specific rates. For example, a transcription factor using one fold to bind DNA
rather than another one should be indistinguishable from one using a different fold, provided binding specificity and
regulatory action are the same.
In view of these considerations, we believe that our findings support a more complex scenario for the interplay
between domain families and their functions. Specifically, we put forward two complementary rationalizations, both
of which are probably in part verified in the data. The first is that functional annotations group together different
domains whose abundance is linked in different ways to genome size because of their different biochemical and bi-
ological functional roles. Such differences may range from slight biochemical specificities of different folds to plain
misannotations. This is possible, e.g., with enzymes, where the biochemical range of two different folds is generally
9Detailed function βi ≤ 0.6 0.6 < βi < 1.4 βi ≥ 1.4 βc ± σβc
Translation 20(4.3) 1(−3.7) 0 0.16± 0.03
DNA replication/repair 11 7 0 0.51± 0.07
Transport 5 9 1 1.1± 0.2
Proteases 7 9 0 0.9± 0.1
Protein modification 8 1(−2.3) 2 1.06± 0.09
Ion m/tr 11 3 3(−2.2) 1.3± 0.1
Other enzymes 29 32 2 1.04± 0.06
Coenzyme m/tr 17(2.2) 6 1 0.85± 0.09
Redox 4(−3.3) 18(3.1) 2 1.2± 0.1
Energy 11 7 0 0.86± 0.09
Nucleotide m/tr 16(3.1) 3(−2.5) 0 0.53± 0.08
Carbohydrate m/tr 4 8 0 1.0± 0.2
Transferases 5 11 1 1.05± 0.07
Amino acids m/tr 7 6 0 0.8± 0.2
DNA-binding 5 4 4(3.3) 1.5± 0.1
Signal transduction 1(−2.7) 5 5(5.0) 1.6± 0.2
Unknown function 9 7 0 0.98± 0.09
TABLE I. Family scaling exponents can be associated to specific biological functions. Each cell in the table indicates the number
of families that functional categories (rows) share with groups of families whose scaling exponents fall in pre-defined intervals
(columns). The table also shows the Z-scores for a standard hypergeometric test (shown in green for over-representation and
in red for under-representation, only |Z| >1.96 are shown).
different. This obervation might be related to the positive correlation we found between the number of EC numbers
corresponding to a metabolic domain and its scaling exponent. However, such interpretation might be less likely ap-
plicable to, e.g., transcription factor DNA-binding domains, where functional annotation is fairly straightforward [27],
but different scaling behaviors with genome size are nevertheless found.
The second potential explanation assumes the point of view where scaling laws are the result of functional inter-
dependency between different domain families [8, 28], then correlated fluctuations around the mean of family pairs
should carry memory of such dependency structures [12]. More in detail, there may be specific dependencies connect-
ing the relative proportions of domains with both different and equal functional annotations that are present in the
same genome, which might determine the family-specific behavior [5]. While further analysis is required to elucidate
these trends, we believe that gaining knowledge on functional dependencies would be an important step to understand
the functional design principles of genomes.
Of notable importance is the case of the superlinear scaling of transcription factors, which has created notable debate
in the past [8, 29]. For the first time, we look into how this trend is subdivided between the different DBDs [27]. Our
analysis indicates that the superlinear scaling is driven by the few most abundant superfamilies (mostly winged-helix,
homeodomain, lambda repressor). However, the remaining 10-20% of the functional category gives a clear sublinear
scaling with genome size, which emerges beyond any sampling problems. We speculate that these other regulatory
DNA-binding domains may be functionally different or behave differently over evolutionary time scales. Hence, the
scaling of transcription factors with size in bacteria is driven by a small set of domain families with scaling exponent
close to two, which take up most of the abundance, but does not appear to be peculiar of all transcription factors. A
“toolbox” model considering the role of transcription factors as regulator of metabolic pathways and the finite universe
of metabolic reactions [8, 11] predicts scaling exponents close to two for transcription factor families. According to our
results, such model should be applicable to the leading TF families. Interestingly, the heterogeneity in the behavior
in transcription factor DNA-binding domains is much higher than that of the other notable superlinear functional
category, signal transduction, where removal of the leading families does not significantly affect the observed scaling
of abundance with genome size. Given the clarity and uniformity of the scaling exponent, we speculate that possibly
a toolbox-like model may be applicable to understand the overall scaling of this category.
Other categories clearly contain multiple sets of families with coherent exponents or single outlier families. In
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some cases, two main groups of families with different scaling behavior clearly emerge, and higher observed scaling
exponents may be related to a wider range of functional annotations. We propose that such easily detectable trends
can be used to revise and refine functional annotations of protein domains. Such functional annotations are currently
largely curated by humans, and based on subjective and/or biased criteria. The analysis of family scaling gives an
additional objective test to define the coherence of the families that are annotated under the same function. While
yet-to-be-developed automated inference methods based on our observations could serve this purpose, the quantitative
scores defined here already provide useful information. The heterogeneity of a functional category is an indication
of how likely that group of domain families follows a coherent expansion rate over evolution. The enrichment scores
for sets of families with a given range of scaling exponent helps to pinpoint the sets of families within the functional
category that expand coherently with genome size.
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SUPPLEMENTARY NOTES
S1. FILTERS FOR RELIABLE FAMILY SCALING
Many domain families are found only in a few genomes and/or in very few copies. For this reason, they might not
show clear scaling properties. We excluded such families from the analysis with some filtering criteria. In order to
filter out these families, we used three independent parameters. The first one is the occurrence of a family (i.e., the
fraction of genomes where it is present, and the number of points available for the fit), the second one is the Pearson
correlation of its abundance with genome size and the third one is the goodness of fit to a power law.
The occurence of the family i is defined as
oi =
N
(i)
G
NG
, (1)
while N
(i)
G is the number of genomes in which family i is present and NG is the total number of genomes in the sample.
The Pearson correlation coefficient ρi between the logarithm of the family abundance and the logarithm of the
genome size quantifies the existence of a relation between family abundance and genome size. It should be noted
that this quantity differs from oi: these two properties are not correlated in the data (Fig. S1B), which indicates that
filters on their value should be applied independently.
Considering families with clear but shallow scaling or constant abundance across genomes, the Pearson correlation
index gives values close to zero, or slighlty negative, therefore another parameter is required to assess the accuracy of
the fit results. For each family whose estimated scaling exponent is lower than 0.2, we defined the quantity LSi as
LSi =
1
N
(i)
G
N
(i)
G∑
g=1
[yfit,i − yi]2
yfit
,
where yi is the logarithm of the empirical abundance of family i and yfit,i is the abundance calculated with the fit
parameters, i.e.,
yfit,i = αi + βi log
(
NF∑
i=1
ngi
)
.
The goodness of fit index si was defined as
si =
1
1 +
√
LSi
so that the values of si close to 1 correspond to the minimum value of the average squared deviation between the fit
and the empirical values. The goodness of fit index si is independent from the occurrence oi as shown in Fig. S1A.
We considered only the families with oi > 0.6. If the fitted scaling exponent is higher than 0.2 then we excluded
the families with ρi < 0.4, while, for exponents lower than 0.2, only families with si > 0.9 were taken into account.
After this thresholding, we removed 1179 families out of 1536. While the fraction of such small and sparse families is
large, we verified that they do not contribute significantly to the category scaling (see Figure S2).
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S2. FORMULATION OF THE NULL MODEL FOR FAMILY-SPECIFIC SCALING
The null model assumes that the total abundance of a category is distributed randomly across the families belonging
to it. Both the average relative abundance (i.e. fraction of domains belonging to a family averaged over genomes)
and occurrence (fraction of genomes where the family is present) of each family are conserved (they are in fact two
independent properties, see Fig. S3).
The null model is based on the following ingredients.
• The number of domains belonging to a category c in genome g, ngi , is conserved.
• For each genome, domains are not assigned to families that are not present in that genome.
• The average frequency for each family with respect to the category is conserved.
The average frequency fc(i) of the family i with respect to the category c is defined as
fc(i) =
1
N
(i)
G
∑
g
ngi
ngc
, (2)
where the family index i belongs to the set in category c and the sum over g is carried over all the genomes, while N
(i)
G
is the number of genomes in which family i is present, ngi is the abundance of family i in genome g and n
g
c =
∑
i∈c n
g
i
is the abundance of category c in genome g.
Given a genome g, each realization of the null model redistributes randomly the ngc domains of the functional
category c arranged in the F gc families belonging to category c in genome g. Each one of the n
g
c domains is assigned
to family i with probability
pc(i) =

fc(i)∑
i∈c fc(i)
, if ngi 6= 0
0, if ngi = 0 .
(3)
S3. ENRICHMENT ANALYSIS FOR FUNCTIONAL CATEGORIES AND FAMILIES WITH SIMILAR
SCALING EXPONENT
All families passing the filters described in section S1 were divided into three groups based on the values of their
exponent βi:
• sub-linearly scaling families, βi ≤ 0.6
• linearly scaling families, 0.6 < βi < 1.4
• super-linearly scaling families, βc ≥ 1.4
We used hypergeometric tests to asses over- or under-representation of functional categories in these family groups.
Given that Fc is the number of families that belong to the category c, Fbin is the number of families in either of
the three groups defined above and Ftot is the total number of families involved in this analysis, the mean and the
variance of the hypergeometric distribution are:
µbin,c = Fbin · Fc
Ftot
,
σ2bin,c = Fbin ·
Fc
Ftot
·
(
1− Fc
Ftot
)
·
(
1− Fbin − 1
Ftot − 1
)
,
For each combination of functional category and family group, the quantity xbin,c is the number of families that lie
in the intersection of category c with family group bin. The functional category c is under-represented in the group
bin if Zbin,c < −1.96, over-represented if Zbin,c > −1.96, where Zbin,c is the Z-score:
Zbin,c =
xbin,c − µbin,c
σbin,c
,
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The resulting intersection values xbin,c and the significant Z-scores are reported in Table 1 of the main text.
In order to prove that the results are independent from the chosen interval of the exponents, we substituted the
three groups with sliding intervals of amplitude 0.4 and step 0.1 and repeated the same process. Only intervals with
more than 10 families are considered. Fig. S9 shows that the results are consistent with the previous analysis. Fig. S10
shows how the exponent corresponding to the maximum Z-score differs in some cases from the category exponent.
S4. MAIN RESULTS HOLD ALSO FOR PFAM CLANS
We chose PFAM clans as an alternative database to test our results. PFAM clans were annotated on the same
scheme of 50 functional categories used for superfamilies, using the mapping of clans into superfamilies available from
the PFAM website http://pfam.xfam.org/clan/browse#numbers [21]. The scaling laws for functional categories
are recovered also for clans (Fig. S11 and Table S3) and are consistent with previous results [1–6].
The following main results were recovered for Pfam clans.
• For each clan, the abundance across genomes scaleS as a power law of the genome size. Equally to SCOP
superfamilies, Pfam clans have individual scaling exponents that may or may not follow the one of the associated
functional category (Table. S5). The fitting method and threshold values are the same used for supefamilies
(sec. S1). 178 clans out of 446 passed the filters and were employed for further analysis.
• The heterogeneity (average of the distance between the category exponent and the clan exponent), positively
correlates with the category exponent (Fig. S12). Functional categories with superlinear scaling tend to be more
heterogeneous and, as found for superfamilies, the functional category Signal Transduction is less heterogeneous
than DNA-binding, although having the largest exponent. Unlike the case of superfamilies, Protein Modification
does not have high heterogeneity score, but the difference in scaling between the (strongly superlinear) outlier
family Gro-ES and the remaining ones is observed. For clans, the scaling of Protein Modification is once again
strongly biased by the clan “GroES-like superfamily” (20% of the total domains).
• Either few or most of the clans determine the scaling exponent of the functional category they belong to.
Figure S8 is coherent with what observed for superfamilies, in particular the functional category of DNA-
binding is dominated by one clan (the “Helix-turn-helix” clan) that accounts for 83% of the total domains. As
for superfamilies, Signal Trasduction is robust to the progressive removal of families confirming that the presence
of dominant clans is not related to the superlinear scaling of the category.
• Grouping clans with similar scaling exponents recovers known associations between the category exponent and
the biological function (Fig. S13).
S5. CORRELATION BETWEEN FAMILY SCALING AND EC NUMBERS
The Enzyme Commission (EC) number is a classification scheme for enzyme-catalyzed chemical reactions. It is
built as a four-levels tree where the top nodes are six main groups of reactions, namely Oxidoreductases, Transferases,
Hydrolases, Lyases, Isomerases and Ligases. We used the mapping between Superfamilies and EC terms [17], to
investigate the correlation between the Superfamily scaling and the number of different reactions in which the family
is involved. This quantity is the count of distinct EC numbers corresponding to the finest level of the EC classification.
This number shows a positive correlation (Spearman 0.74) with the scaling exponent of metabolic family (see Table S2).
The diversity of EC numbers in metabolic families is also correlated with the mean total abundance of a family, since
family abundance and scaling exponent are also correlated (Spearman 0.72).
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Supplementary Figure S1. The parameters used to filter out families are independent. (A) The plot reports the
goodness of fit index si, which is the average squared deviation between the empirical family abundance and the one derived
from the fit, as a function of family occurrence. Each point represents a family whose exponent is lower than 0.2 . (B) Pearson
correlation between family abundance (number of domain belonging to a given family) and genome size, calculated across the
genomes where the family is present as a function of family occurrence. Each point represents a family whose exponent is
higher than 0.2 . The lack of clear correlation visible in the plots shows that the three indices are all relevant in the filters.
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Supplementary Figure S2. Category exponents are robust by removal of filtered families. The plot compares the
category exponent obtained by considering all the domains and the exponent obtained by removing from the category count
the domains belonging to families filtered out by our criteria for unclear scaling. The exponents before (x-axis) and after
thresholding (y-axis) are compatible within their errors. The solid line is the y = x line. The panel on the right shows the
association between symbols and category codes (see Table S1 for the corresponding category name).
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Supplementary Figure S3. Absence of correlation between family frequency and occurrence in empirical data.
Ratio between the family frequency and family occurrence plotted vs family occurrence. The frequency of a family in a genome
is defined as the ratio between its abundance and the genome size in domains, i.e. the total number of domains found on the
genome. The plot shows that there is no clear correlation between the two quantities, implying that universally found (“core”)
families are not necessarily more abundant than rare families, and viceversa. Note that, given a value of occurence, there is
a technical lower bound to the frequency. If a family is present in G genomes, the mimimum value that the frequency can
assume is when the family is present with only one domain in the G largest genomes, and therefore have frequency lower than
the inverse of the size of the G-th largest genome. It is expected that the lower bound increases with occurrence.
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Supplementary Figure S4. Family exponents differ significantly from the null expectation set by the scaling of the
associated functional category. In order to account for random fluctuations in family composition within a category, the
family-exponents (colored symbols with error bars) were compared with the ones calculated randomizing the data accordingly
to the null model presented in section S2 (black squares, error bars are variability across 1000 realizations). The variability
obtained from the null model is extremely low and is not sufficient to explain the variability of scaling exponents of different
families within a category. Each panel corresponds to a different functional category, its scaling exponent is shown as the black
horizontal line. Families within each category are sorted in decreasing order of abundance, i.e. total domain count in the
category.
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Supplementary Figure S5. Scaling of the abundance of domains belonging to the least abundant families. We
progressively removed families from the category in decreasing order of family abundance and represented the scaling of the
abundance of the remaining stripped category (y-axis) with genome size (x-axis). The scaling of the stripped category with
≈ 40% initial abundance is shown in light green, while the category with ≈ 10% of the initial abundance in dark green. The
scaling of the original category is shown with a different color (category-specific, as in Fig. 1 and 2 of the Main Text) in each
panel.
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Supplementary Figure S6. Systematic removal procedure showing the role of family abundance in building the
scaling laws of functional categories. Same as Fig. 3B of the main text, for all the categories. Grey circles represent the
exponents βi (and their errors as error bars) for the scaling law of each family belonging to the functional category (in order of
rank in total abundance). Cyan circles are the scaling exponents of stripped functional categories, without the domains of the
i most abundant families. The size of each symbol is proportional to the fraction of domains in the family or family-stripped
category. Error bars are uncertainties of the fits (see Methods).
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Supplementary Figure S7. The Signal Transduction funcitonal category shows the most coherent superlinear
scaling, with exponent close to 2. Same as Fig. 3B of the main text for the functional category Signal Transduction. Grey
circles represent the exponents βi (and their errors) for the scaling law of each family belonging to the functional category (in
order of rank in total abundance). Orange circles are the scaling exponents of Signal Transduction without the domains of the
i most abundant families. The size of each symbol is proportional to the fraction of domains in the family or family-stripped
category. Error bars are uncertainties of the fits (see Methods).
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Supplementary Figure S8. Systematic removal of families (ranked by abundance) from functional categories reveals
how individual families build up functional category scaling. Same as Figure 3B of the main text and Figure S6, for
Pfam clans. Grey circles represent the exponents βi (and their errors) for the scaling law of each clan (instead of SUPFAM
families) belonging to the functional category (in order of rank in total abundance). Colored circles are the scaling exponents
of functional categories without the domains of the i most abundant clans. The size of each symbol is proportional to the
fraction of domains in the clan or clan-stripped category. Error bars are uncertainties of the fits (see Methods).
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Supplementary Figure S9. A functional enrichment test for sets of families with similar scaling exponents. Families
are grouped into sliding bins according to the value of their scaling exponent and tested for enrichment against each functional
category. Each panel shows the results of the enrichment test for all functional categories with more than 10 families. The
x-axis represents the center of the interval of exponents defining the family set. The y-axis is the corresponding Z-score for
the enrichment test (see Sec. S3), shown green if the Z-score is positive, in red if it is negative. Non-transparent squares are
for significant Z-scores, the grey area delimits |Z-scores| >1.96. High Z-score peaks in this plot represent enrichment for the
functional category in a specific exponent range. The cyan vertical line indicates the category exponent.
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Supplementary Figure S10. Comparison of the category exponent with the exponent corresponding to the
maximum Z-score in the enrichment test in Fig. S8 (see Sec. S3). The black line is the y = x line. Correspondence
with this line indicates clear association between the functional category and the scaling exponent range. The panel on the
right shows the association between symbols and category codes (see Table S1 for the corresponding category name).
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Supplementary Figure S11. Comparison of the scaling of functional categories with gneome size in SUPERFAMILY
database and Pfam database. The figure shows the fitted power-law scaling of the SUPERFAMILY (solid lines) and Pfam
(dashed lines) categories. The chosen categories are DNA-binding (red), Translation (green) and all metabolic categories (blue).
The categories show similar exponents (but different prefactors) in the two databases.
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Supplementary Figure S12. Functional categories of Pfam clans with faster scaling exponents contain clans with
more heterogeneous scaling laws. Same as Figure 2A of the Main Text, for Pfam clans. Heterogeneity is quantified by
the mean deviation between the clan scaling exponents and the category exponent. The plot reports heterogeneity scores
for different functional categories, plotted as a function of the category exponents. Each symbol corresponds to a different
functional category. Only categories with more than 5 clans are shown. The right panel shows the association between symbols
and category codes (see Table S1 for the corresponding category name).
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Supplementary Figure S13. Functional enrichment of sets of Pfam clans with similar scaling exponents. Same as
Fig. S10 for Pfam clans. Comparison of the category exponent with the exponent corresponding to the maximum Z-score in the
enrichment test (see Sec. S3). Clans are grouped into sliding bins according to the value of their scaling exponent and tested for
enrichment against each functional category. The exponent corresponding to the maximal value of Z-score (y-axis) is compared
to the category scaling exponent (x-axis). The black line is the y = x line. Correspondence with this line indicates clear
association between the functional category and the scaling exponent range. The right panel shows the association between
symbols and category codes (see Table S1 for the corresponding category name).
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SUPPLEMENTARY TABLES
Supplementary Table S1: Symbols and codes used to identify func-
tional categories.
symbol category code category name
C C Energy
E Amino acids met./tr.
F Nucleotide met./tr.
G Carbohydrate met./tr.
H Coenzyme met./tr.
J Translation
L DNA replication
LA DNA binding
O Protein modification
OA Proteases
P Ion met./tr.
RA Redox
RB transferase
RC Other enzymes
RF Transport
S Unknown function
T Signal transductino
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Supplementary Table S2. Spearman correlations among family parameters. The table reports Spearman correlation
coefficients between sets of family parameters, comparing biological/evolutionary and abundance properties. Each row de-
scribes biological parameters: for the Superfamily database we used the foldability (quantified by size-corrected contact order,
SMCO [23]) and the diversity of EC-numbers (quantifying the functional plasticity of a given family, see Section S5) associated
with families. For Pfam families, we considered the Hidden Markov Model sequence length (Hmm length) and the evolutionary
rate (retrieved from [24]). The parameters listed in columns are the exponent and prefactor of the family scaling law (βi and
αi respectively), the mean family abundance calculated over all genomes (〈ai〉) and the ratio between the average relative
abundance (see definition of frequency in Section S2) and family occurrence (fi/oi). Relevant correlations are found for the
diversity in EC numbers restricted to metabolic families and the scaling exponent βi, as well as with the mean and relative
family abundance. Family abundance and scaling exponent are also correlated (Spearman 0.72).
database parameters βi αi 〈ai〉 fi/oi
SUPFAM
SMCO −0.06 0.07 0.04 0.04
EC numbers
0.22 −0.14 0.40 0.35
(not met. families)
EC numbers
0.64 −0.50 0.77 0.74
(met. families)
PFAM
Hmm length 0.13 −0.13 0.10 0.10
Ka/Ks 0.11 −0.12 0.03 0.05
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Supplementary Table S3: Scaling exponent of functional cate-
gories. The table reports the scaling exponent βc of all functional cat-
egories examined, both for superfamilies (SUPFAM column) and clans
(PFAM column). The error associated with the exponent is calculated
as the root mean square deviation of the logarithm of the category abun-
dance across all genomes from the estimated scaling law (see Methods).
cat. code category name βc ± σβc (Supfam) βc ± σβc (Pfam)
A RNA binding, met./tr. 0.4± 0.1 0.21± 0.10
B Chromatin structure 0.6± 0.3 −−
C Energy 0.8± 0.1 0.94± 0.09
CA E-transfer 1.8± 0.3 1.73± 0.34
CB Photosynthesis 0.9± 0.4 0.56± 0.28
D Cell cycle, Apoptosis 1.2± 0.2 −−
E Amino acids m/tr 0.9± 0.2 1.09± 0.17
EA Nitrogen m/tr 1.8± 0.2 −−
F Nucleotide m/tr 0.5± 0.1 0.70± 0.17
G Carbohydrate m/tr 1.0± 0.2 1.38± 0.31
GA Polysaccharide m/tr 1.1± 0.2 1.13± 0.20
H Coenzyme m/tr 0.9± 0.1 1.27± 0.18
HA Small molecule binding 0.9± 0.1 0.74± 0.06
HD Receptor activity 1.3± 0.5 0.25± 0.20
HE Ligand binding 0.3± 0.1 1.19± 0.31
I Lipid m/tr 1.2± 0.2 1.31± 0.20
IA Phospholipid m/tr 0.6± 0.3 0.77± 0.25
J Translation 0.16± 0.03 0.17± 0.05
K Transcription 0.9± 0.1 0.98± 0.19
L DNA replication/repair 0.5± 0.1 0.63± 0.07
LA DNA-binding 1.5± 0.1 1.49± 0.13
LB RNA processing 0.2± 0.1 0.07± 0.12
M Cell envelope m/tr 0.7± 0.4 −−
MA Cell adhesion 1.3± 0.3 1.49± 0.29
N Cell motility 0.7± 0.3 0.48± 0.20
O Protein modification 1.1± 0.1 0.99± 0.13
OA Proteases 1.0± 0.1 1.01± 0.10
OB Kinases/phosphatases 1.3± 0.2 1.02± 0.31
P Ion m/tr 1.3± 0.1 1.04± 0.17
Q Secondary metabolism 1.5± 0.2 2.01± 0.29
R General 1.2± 0.2 1.61± 0.23
RA Redox 1.2± 0.1 1.19± 0.13
RB Transferases 1.1± 0.1 1.13± 0.09
RC Other enzymes 1.1± 0.1 1.13± 0.06
RD Protein interaction 1.0± 0.2 0.93± 0.19
RF Transport 1.1± 0.2 1.10± 0.16
S Unknown function 1.0± 0.1 0.89± 0.13
SB Toxins/defense 1.1± 0.3 1.28± 0.29
T Signal transduction 1.6± 0.2 1.74± 0.20
TA Other regulatory function 1.1± 0.2 0.55± 0.24
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Supplementary Table S4: Scaling exponent of superfamilies from
the SUPERFAMILY database. The abundance of a (super)family
scales as a power law of the genome size with family-dependent scaling
exponents βi. Each row corresponds to a domain family and shows its
scaling exponent along with its error (see Methods) and the category to
which the family belongs (category code). Families corresponding to the
same functional category are ordered in decreasing order of abundance.
cat. code family name βi ± σβi
A Alpha-L RNA-binding motif 0.2± 0.1
A PUA domain-like 0.7± 0.2
C 6-phosphogluconate dehydrogenase C-terminal domain-like 1.2± 0.2
C
Glyceraldehyde-3-phosphate dehydrogenase-like,
1.0± 0.2
C-terminal domain
C Phosphoenolpyruvate/pyruvate domain 1.0± 0.2
C SIS domain 0.7± 0.2
C LeuD/IlvD-like 0.9± 0.2
C Enolase C-terminal domain-like 0.8± 0.2
C Transmembrane di-heme cytochromes 0.5± 0.3
C Aconitase iron-sulfur domain 0.5± 0.2
C Cytochrome c oxidase subunit I-like 0.5± 0.2
C
UDP-glucose/
0.5± 0.2
GDP-mannose dehydrogenase C-terminal domain
C Citrate synthase 0.6± 0.2
C PEP carboxykinase-like 0.2± 0.2
C Cytochrome c oxidase subunit III-like 0.4± 0.2
C PK C-terminal domain-like 0.2± 0.1
C
Enzyme I of the PEP:sugar phosphotransferase
0.4± 0.2system HPr-binding (sub)domain
C Cytochrome c oxidase subunit II-like, transmembrane region 0.3± 0.2
CA Cytochrome c 1.0± 0.5
CA Acyl-CoA dehydrogenase C-terminal domain-like 2.0± 0.4
CA FMN-dependent nitroreductase-like 0.8± 0.3
CA ISP domain 1.2± 0.3
CA Sulfite reductase hemoprotein (SiRHP), domains 2 and 4 0.9± 0.2
CA
Succinate dehydrogenase/fumarate reductase flavoprotein,
0.7± 0.2catalytic domain
CB PRC-barrel domain 0.7± 0.3
D Rhodanese/Cell cycle control phosphatase 1.1± 0.3
E ACT-like 0.8± 0.2
E
Tryptophan synthase beta subunit-like
1.0± 0.2
PLP-dependent enzymes
E Carbamate kinase-like 0.5± 0.1
E PLP-binding barrel 0.7± 0.1
E Glutamine synthetase/guanido kinase 0.7± 0.2
E L-aspartase-like 0.7± 0.2
E Diaminopimelate epimerase-like 0.5± 0.2
E Alanine racemase C-terminal domain-like 0.5± 0.2
E Aspartate/glutamate racemase 0.3± 0.2
E Arginase/deacetylase 0.8± 0.2
E Aspartate/ornithine carbamoyltransferase 0.3± 0.1
E Serine metabolism enzymes domain 0.3± 0.2
E Chorismate mutase II 0.4± 0.2
EA RmlC-like cupins 1.8± 0.2
F Ribonuclease H-like 0.7± 0.3
F Adenine nucleotide alpha hydrolases-like 0.9± 0.1
F Nucleotidylyl transferase 0.17± 0.05
F PRTase-like 0.4± 0.1
F Nucleotidyltransferase 0.7± 0.2
F Pseudouridine synthase 0.3± 0.1
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F Ribulose-phoshate binding barrel 0.5± 0.2
F Tetrahydrobiopterin biosynthesis enzymes-like 0.4± 0.2
F Purine and uridine phosphorylases 0.3± 0.2
F Nucleotidyltransferase substrate binding subunit/domain 0.2± 0.2
F Nicotinate/Quinolinate PRTase C-terminal domain-like 0.4± 0.2
F
Nucleoside phosphorylase/
0.3± 0.2phosphoribosyltransferase catalytic domain
F
Nucleoside phosphorylase/
0.4± 0.2phosphoribosyltransferase N-terminal domain
F NadA-like 0.00± 0.03
G (Trans)glycosidases 1.4± 0.4
G Aldolase 0.9± 0.2
G Phosphoglucomutase, first 3 domains 0.4± 0.1
G Galactose-binding domain-like 0.8± 0.5
G Six-hairpin glycosidases 1.2± 0.4
G Duplicated hybrid motif 0.5± 0.2
G Xylose isomerase-like 1.0± 0.3
G Carbohydrate phosphatase 0.6± 0.2
G HIT-like 0.6± 0.2
G Phosphoglucomutase, C-terminal domain 0.4± 0.1
G PK beta-barrel domain-like 0.9± 0.2
G HPr-like 0.2± 0.2
GA UDP-Glycosyltransferase/glycogen phosphorylase 1.0± 0.2
GA Pectin lyase-like 1.3± 0.4
GA Glycosyl hydrolase domain 0.8± 0.3
GA Barwin-like endoglucanases 0.5± 0.2
H Glutathione synthetase ATP-binding domain-like 0.9± 0.1
H Acyl-CoA dehydrogenase NM domain-like 2.0± 0.4
H PreATP-grasp domain 0.7± 0.1
H Single hybrid motif 0.8± 0.2
H FMN-binding split barrel 1.2± 0.2
H Riboflavin synthase domain-like 1.0± 0.2
H Succinyl-CoA synthetase domains 0.5± 0.2
H YrdC/RibB 0.5± 0.2
H Molybdenum cofactor biosynthesis proteins 0.6± 0.2
H Dihydrofolate reductase-like 0.6± 0.2
H UROD/MetE-like 0.5± 0.3
H Dihydropteroate synthetase-like 0.4± 0.2
H Cobalamin (vitamin B12)-binding domain 0.4± 0.3
H Activating enzymes of the ubiquitin-like proteins 0.4± 0.2
H Nicotinate/Quinolinate PRTase N-terminal domain-like 0.4± 0.2
H Glutamine synthetase, N-terminal domain 0.6± 0.2
H Peptide deformylase 0.2± 0.2
H RibA-like 0.4± 0.2
H MoeA C-terminal domain-like 0.2± 0.2
H ApbE-like 0.3± 0.2
HA P-loop containing nucleoside triphosphate hydrolases 0.71± 0.08
HA NAD(P)-binding Rossmann-fold domains 1.4± 0.1
HA FAD/NAD(P)-binding domain 1.3± 0.2
HA Thiamin diphosphate-binding fold (THDP-binding) 0.9± 0.1
HA FAD-binding domain 1.0± 0.2
HA Nucleotide-binding domain 0.8± 0.2
HA Sensory domain-like 0.7± 0.4
HD
Methyl-accepting chemotaxis protein (MCP)
1.0± 0.5
signaling domain
HD PhoU-like 0.3± 0.2
HE TGS-like 0.3± 0.1
I Thioesterase/thiol ester dehydrase-isomerase 1.5± 0.2
I
Probable ACP-binding domain of
1.0± 0.3
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malonyl-CoA ACP transacylase
I Creatinase/prolidase N-terminal domain 0.5± 0.2
I
Prokaryotic lipoproteins and
0.4± 0.2
lipoprotein localization factors
IA PLC-like phosphodiesterases 0.6± 0.2
J Ribosomal protein S5 domain 2-like 0.30± 0.07
J Translation proteins 0.26± 0.06
J EF-G C-terminal domain-like 0.30± 0.09
J Sm-like ribonucleoproteins 0.8± 0.3
J Triger factor/SurA peptide-binding domain-like 0.3± 0.2
J ValRS/IleRS/LeuRS editing domain 0.03± 0.04
J Release factor 0.2± 0.1
J L30e-like 0.3± 0.2
J EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain 0.5± 0.2
J S13-like H2TH domain 0.3± 0.2
J NusB-like 0.3± 0.1
J ClpS-like 0.4± 0.1
J Ribosome binding protein Y (YfiA homologue) 0.3± 0.1
K Tetracyclin repressor-like, C-terminal domain 2.4± 0.3
K LexA/Signal peptidase 0.6± 0.2
K Poly A polymerase C-terminal region-like 0.2± 0.2
K GreA transcript cleavage protein, N-terminal domain 0.2± 0.1
K CYTH-like phosphatases 0.3± 0.1
L Nucleic acid-binding proteins 0.31± 0.07
L DNA breaking-rejoining enzymes 1.0± 0.3
L Nudix 1.2± 0.2
L RuvA domain 2-like 0.4± 0.1
L Restriction endonuclease-like 0.8± 0.3
L DNA/RNA polymerases 0.8± 0.2
L DNA-glycosylase 0.7± 0.2
L DNase I-like 0.8± 0.2
L
DNA polymerase III clamp loader subunits,
0.2± 0.1
C-terminal domain
L Resolvase-like 0.4± 0.4
L Uracil-DNA glycosylase-like 0.6± 0.2
L GIY-YIG endonuclease 0.4± 0.2
L DNA ligase/mRNA capping enzyme, catalytic domain 0.7± 0.2
L HRDC-like 0.4± 0.2
L N-terminal domain of MutM-like DNA repair proteins 0.4± 0.2
L TRCF domain-like 0.02± 0.03
LA Winged helix DNA-binding domain 1.8± 0.2
LA Homeodomain-like 2.2± 0.3
LA lambda repressor-like DNA-binding domains 1.4± 0.3
LA
C-terminal effector domain of
1.8± 0.2
the bipartite response regulators
LA Periplasmic binding protein-like I 1.4± 0.4
LA Putative DNA-binding domain 1.1± 0.2
LA
Fatty acid responsive transcription factor FadR,
1.9± 0.3C-terminal domain
LA Glucocorticoid receptor-like (DNA-binding domain) 0.4± 0.2
LA TrpR-like 0.4± 0.3
LA Ribbon-helix-helix 0.8± 0.3
LA IHF-like DNA-binding proteins 0.3± 0.3
LA ParB/Sulfiredoxin 0.6± 0.3
LA KorB DNA-binding domain-like 0.4± 0.3
LB EPT/RTPC-like 0.3± 0.1
M OmpA-like 0.9± 0.4
MA vWA-like 1.2± 0.3
MA Pili subunits 0.8± 0.4
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MA PGBD-like 0.7± 0.3
MA Hedgehog/DD-peptidase 0.5± 0.2
O
ATPase domain of HSP90 chaperone/
1.5± 0.2DNA topoisomerase II/ histidine kinase
O GroES-like 1.6± 0.3
O FKBP-like 0.6± 0.2
O Chaperone J-domain 0.5± 0.2
O Cyclophilin-like 0.9± 0.2
O Double Clp-N motif 0.6± 0.2
O HSP20-like chaperones 0.6± 0.2
O GroEL equatorial domain-like 0.2± 0.2
O GroEL apical domain-like 0.2± 0.2
O Peptide methionine sulfoxide reductase 0.2± 0.2
O GroEL-intermediate domain like 0.2± 0.1
OA ClpP/crotonase 1.0± 0.2
OA Zn-dependent exopeptidases 1.0± 0.2
OA Metallo-dependent phosphatases 1.0± 0.2
OA Metalloproteases (”zincins”), catalytic domain 0.8± 0.3
OA LuxS/MPP-like metallohydrolase 0.5± 0.3
OA Cysteine proteinases 1.0± 0.3
OA Bacterial exopeptidase dimerisation domain 1.1± 0.3
OA Trypsin-like serine proteases 1.0± 0.3
OA Creatinase/aminopeptidase 0.5± 0.1
OA HSP40/DnaJ peptide-binding domain 0.3± 0.2
OA DPP6 N-terminal domain-like 0.6± 0.4
OA Subtilisin-like 0.8± 0.3
OA Rhomboid-like 0.5± 0.2
OA Macro domain-like 0.3± 0.2
OA Tricorn protease N-terminal domain 0.4± 0.2
OB Protein kinase-like (PK-like) 1.2± 0.3
OB PP2C-like 0.8± 0.3
OB Phosphohistidine domain 0.7± 0.2
OB Phosphotyrosine protein phosphatases I 0.6± 0.2
OB Acylphosphatase/BLUF domain-like 0.3± 0.2
P Periplasmic binding protein-like II 1.6± 0.3
P MFS general substrate transporter 1.4± 0.3
P Multidrug resistance efflux transporter EmrE 1.3± 0.3
P HlyD-like secretion proteins 1.5± 0.4
P Ferritin-like 1.0± 0.2
P Cupredoxins 1.1± 0.3
P Calcium ATPase, transduction domain A 0.6± 0.2
P Calcium ATPase, transmembrane domain M 0.6± 0.2
P TrkA C-terminal domain-like 0.6± 0.3
P HMA, heavy metal-associated domain 0.4± 0.2
P Band 7/SPFH domain 0.5± 0.2
P Fe-S cluster assembly (FSCA) domain-like 0.4± 0.2
P Voltage-gated potassium channels 0.6± 0.2
P Magnesium transport protein CorA, transmembrane region 0.5± 0.2
P CorA soluble domain-like 0.5± 0.2
P Clc chloride channel 0.3± 0.2
Q Dimeric alpha+beta barrel 2.1± 0.3
Q Clavaminate synthase-like 1.6± 0.3
Q Concanavalin A-like lectins/glucanases 0.8± 0.4
Q Terpenoid synthases 0.7± 0.2
Q
Homo-oligomeric flavin-containing
0.4± 0.2
Cys decarboxylases, HFCD
R Bet v1-like 1.5± 0.4
R Helical backbone metal receptor 0.9± 0.3
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R ADC-like 1.0± 0.3
R ARM repeat 0.6± 0.3
R
Peripheral subunit-binding domain of 2-oxo
0.3± 0.2acid dehydrogenase complex
R Pentein 0.4± 0.2
R JAB1/MPN domain 0.2± 0.2
RA Thioredoxin-like 1.1± 0.2
RA 4Fe-4S ferredoxins 0.8± 0.4
RA Metallo-hydrolase/oxidoreductase 1.1± 0.2
RA
Glyoxalase/Bleomycin resistance protein/
2.1± 0.3Dihydroxybiphenyl dioxygenase
RA ALDH-like 1.5± 0.2
RA 2Fe-2S ferredoxin-like 1.0± 0.3
RA Flavoproteins 0.9± 0.3
RA alpha-helical ferredoxin 0.9± 0.3
RA FAD-linked reductases, C-terminal domain 1.4± 0.3
RA Formate/glycerate dehydrogenase catalytic domain-like 1.0± 0.2
RA NAD(P)-linked oxidoreductase 1.3± 0.3
RA Isocitrate/Isopropylmalate dehydrogenase-like 0.6± 0.2
RA Aminoacid dehydrogenase-like, N-terminal domain 0.7± 0.1
RA
FAD/NAD-linked reductases,
0.7± 0.2
dimerisation (C-terminal) domain
RA Formate dehydrogenase/DMSO reductase, domains 1-3 1.0± 0.3
RA Ferredoxin reductase-like, C-terminal NADP-linked domain 1.0± 0.3
RA Dehydroquinate synthase-like 0.7± 0.3
RA Inosine monophosphate dehydrogenase (IMPDH) 0.5± 0.2
RA Acid phosphatase/Vanadium-dependent haloperoxidase 0.7± 0.2
RA FAD-linked oxidases, C-terminal domain 1.0± 0.3
RA Sulfite reductase, domains 1 and 3 0.6± 0.2
RA
Succinate dehydrogenase/
0.5± 0.2
fumarate reductase flavoprotein C-terminal domain
RA LDH C-terminal domain-like 0.3± 0.2
RA FAD-linked oxidoreductase 0.6± 0.2
RB S-adenosyl-L-methionine-dependent methyltransferases 0.9± 0.1
RB PLP-dependent transferases 1.2± 0.1
RB Acyl-CoA N-acyltransferases (Nat) 1.7± 0.2
RB Nucleotide-diphospho-sugar transferases 0.9± 0.2
RB Class I glutamine amidotransferase-like 1.0± 0.1
RB CoA-dependent acyltransferases 1.0± 0.5
RB NagB/RpiA/CoA transferase-like 1.1± 0.2
RB TK C-terminal domain-like 0.7± 0.2
RB FabD/lysophospholipase-like 1.1± 0.3
RB Tetrapyrrole methylase 1.0± 0.3
RB Glycerol-3-phosphate (1)-acyltransferase 0.7± 0.2
RB Formyltransferase 0.6± 0.1
RB D-aminoacid aminotransferase-like PLP-dependent enzymes 0.5± 0.2
RB 4’-phosphopantetheinyl transferase 0.5± 0.2
RB
Methylated DNA-protein cysteine methyltransferase,
0.8± 0.2C-terminal domain
RB Methylated DNA-protein cysteine methyltransferase domain 0.6± 0.2
RB Homocysteine S-methyltransferase 0.2± 0.2
RC alpha/beta-Hydrolases 1.6± 0.3
RC Actin-like ATPase domain 0.7± 0.1
RC HAD-like 0.9± 0.2
RC Thiolase-like 1.3± 0.3
RC Radical SAM enzymes 0.7± 0.3
RC Acetyl-CoA synthetase-like 1.9± 0.3
RC Metallo-dependent hydrolases 1.3± 0.2
RC HD-domain/PDEase-like 0.7± 0.3
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RC beta-lactamase/transpeptidase-like 0.9± 0.2
RC Trimeric LpxA-like enzymes 0.7± 0.2
RC Lysozyme-like 1.0± 0.2
RC Composite domain of metallo-dependent hydrolases 1.4± 0.2
RC N-terminal nucleophile aminohydrolases (Ntn hydrolases) 1.1± 0.2
RC Ribokinase-like 0.9± 0.2
RC Alkaline phosphatase-like 1.0± 0.3
RC DHS-like NAD/FAD-binding domain 1.2± 0.2
RC Phospholipase D/nuclease 0.8± 0.2
RC Glycoside hydrolase/deacetylase 1.1± 0.2
RC Cytidine deaminase-like 0.6± 0.1
RC LysM domain 0.3± 0.4
RC SGNH hydrolase 0.9± 0.3
RC PurM N-terminal domain-like 0.2± 0.1
RC PurM C-terminal domain-like 0.2± 0.1
RC Phosphoglycerate mutase-like 0.9± 0.3
RC Galactose mutarotase-like 0.6± 0.3
RC Carbon-nitrogen hydrolase 0.8± 0.2
RC PHP domain-like 0.6± 0.2
RC Enolase N-terminal domain-like 0.9± 0.3
RC Quinoprotein alcohol dehydrogenase-like 0.9± 0.3
RC all-alpha NTP pyrophosphatases 0.5± 0.2
RC FAH 1.3± 0.3
RC PFL-like glycyl radical enzymes 0.3± 0.3
RC Amidase signature (AS) enzymes 0.8± 0.3
RC Isochorismatase-like hydrolases 1.2± 0.3
RC L,D-transpeptidase catalytic domain-like 0.9± 0.3
RC Chorismate lyase-like 0.8± 0.3
RC MoCo carrier protein-like 0.5± 0.2
RC NAD kinase 0.5± 0.2
RC ADC synthase 0.4± 0.2
RC Folate-binding domain 0.6± 0.2
RC AraD-like aldolase/epimerase 0.7± 0.2
RC FMT C-terminal domain-like 0.3± 0.2
RC IlvD/EDD N-terminal domain-like 0.7± 0.2
RC Chelatase 0.4± 0.2
RC Aminomethyltransferase beta-barrel domain 0.6± 0.2
RC
2-isopropylmalate synthase LeuA,
10.3± 0.2
allosteric (dimerisation) domain
RC CNF1/YfiH-like putative cysteine hydrolases 0.2± 0.2
RC Nqo1 middle domain-like 0.2± 0.2
RC beta-carbonic anhydrase, cab 0.7± 0.2
RC N-acetylmuramoyl-L-alanine amidase-like 0.3± 0.2
RC post-HMGL domain-like 0.4± 0.2
RC Nqo1C-terminal domain-like 0.2± 0.2
RC DmpA/ArgJ-like 0.4± 0.2
RC Riboflavin kinase-like 0.0± 0.0
RC LigT-like 0.3± 0.2
RD TPR-like 1.2± 0.4
RD FMN-linked oxidoreductases 1.0± 0.1
RD Nqo1 FMN-binding domain-like 0.3± 0.2
RF Multidrug efflux transporter AcrB transmembrane domain 1.2± 0.3
RF
Multidrug efflux transporter AcrB pore domain;
1.2± 0.4PN1, PN2, PC1 and PC2 subdomains
RF
Multidrug efflux transporter AcrB TolC docking domain;
1.2± 0.4DN and DC subdomains
RF CBS-domain 0.9± 0.2
RF ABC transporter transmembrane region 0.7± 0.3
RF NTF2-like 1.6± 0.3
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RF Outer membrane efflux proteins (OEP) 1.2± 0.3
RF ABC transporter involved in vitamin B12 uptake, BtuC 0.8± 0.3
RF Rudiment single hybrid motif 0.8± 0.2
RF
Mechanosensitive channel protein MscS (YggB),
0.6± 0.3
C-terminal domain
RF
Mechanosensitive channel protein MscS (YggB),
0.6± 0.2transmembrane region
RF Proton glutamate symport protein 0.3± 0.3
RF Ammonium transporter 0.3± 0.2
S Sigma2 domain of RNA polymerase sigma factors 1.4± 0.3
S ACP-like 1.3± 0.4
S alpha/beta knot 0.3± 0.1
S E set domains 1.0± 0.3
S MOP-like 1.0± 0.3
S PIN domain-like 0.7± 0.3
S Anti-sigma factor antagonist SpoIIaa 1.1± 0.3
S YjgF-like 1.3± 0.2
S HCP-like 0.4± 0.4
S ITPase-like 0.4± 0.1
S MoaD/ThiS 0.5± 0.2
S YbaK/ProRS associated domain 0.6± 0.2
S Sporulation related repeat 0.3± 0.2
S GatB/YqeY motif 0.3± 0.1
SB AhpD-like 1.5± 0.3
T CheY-like 1.7± 0.2
T PYP-like sensor domain (PAS domain) 2.0± 0.5
T Homodimeric domain of signal transducing histidine kinase 1.6± 0.3
T Nucleotide cyclase 1.6± 0.4
T GAF domain-like 1.7± 0.3
T PDZ domain-like 0.5± 0.2
T EAL domain-like 0.9± 0.4
T cAMP-binding domain-like 1.4± 0.3
T Histidine-containing phosphotransfer domain, HPT domain 1.2± 0.3
T GlnB-like 0.6± 0.2
T Mss4-like 0.6± 0.3
TA
Sigma3 and sigma4 domains of
1.1± 0.2
RNA polymerase sigma factors
TA OsmC-like 1.0± 0.2
TA CinA-like 0.3± 0.1
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Supplementary Table S5: Scaling exponent of Pfam clans. The
abundance of a clan scales as a power law of the genome size with family-
dependent scaling exponents βi. Each row of the table corresponds to a
clan and shows its scaling exponent along with its error (see Methods)
and the corresponding functional category (category code). Clans asso-
ciated to the same functional category are ordered in decreasing order
of abundance.
cat. code clan name βi ± σβi
A S4 domain superfamily 0.29± 0.15
C Pyruvate kinase-like TIM barrel superfamily 1.16± 0.19
C 6-phosphogluconate dehydrogenase C-terminal-like superfamily 1.10± 0.16
C SIS domain fold 0.76± 0.21
C Transmembrane di-heme cytochrome superfamily 0.82± 0.24
C Enolase like TIM barrel 1.13± 0.28
C PFK-like superfamily 0.50± 0.23
C LeuD/IlvD-like 0.52± 0.16
CA Cytochrome c superfamily 0.88± 0.45
CA Acyl-CoA dehydrogenase, C-terminal domain-like 1.95± 0.42
CA Rieske-like iron-sulphur domain 1.15± 0.30
CA FMN-dependent nitroreductase-like 0.78± 0.24
CB PRC-barrel like superfamily 0.57± 0.28
E ACT-like domain 0.70± 0.20
E gamma-glutamylcysteine synthetase/glutamine synthetase clan 0.91± 0.23
E DAP epimerase superfamily 0.51± 0.17
E Arginase/deacetylase superfamily 0.74± 0.24
E Aspartate/glutamate racemase superfamily 0.74± 0.23
F Ribonuclease H-like superfamily 0.78± 0.29
F Nucleotidyltransferase superfamily 0.73± 0.19
F PRPP synthetase-associated protein 1 0.43± 0.15
F Tetrahydrobiopterin biosynthesis-like enzyme superfamily 0.43± 0.20
F Nucleotidyltransferase substrate binding domain 0.37± 0.26
F Purine and uridine phosphorylase superfamily 0.44± 0.21
F dUTPase like superfamily 0.22± 0.15
G Tim barrel glycosyl hydrolase superfamily 1.32± 0.42
G Six-hairpin glycosidase superfamily 1.13± 0.36
G Galactose-binding domain-like superfamily 0.84± 0.46
G inositol polyphosphate 1 phosphatase like superfamily 0.65± 0.24
G HIT superfamily 0.55± 0.23
GA Glycosyl transferase clan GT-B 0.98± 0.19
GA Pectate lyase-like beta helix 1.49± 0.52
GA Glycosyl hydrolase domain superfamily 0.87± 0.26
GA Double Psi beta barrel glucanase 0.55± 0.19
H ATP-grasp superfamily 0.88± 0.15
H Acyl-coenzyme A oxidase/dehydrogenase N-terminal 1.86± 0.42
H Riboflavin synthase/Ferredoxin reductase FAD binding domain 0.90± 0.23
H FMN-binding split barrel superfamily 1.52± 0.27
H Dihydrofolate reductase-like 0.65± 0.23
H Release factor superfamily 0.29± 0.09
H Succinyl-CoA synthetase flavodoxin domain superfamily 0.34± 0.18
HA
P-loop containing nucleoside
0.70± 0.07
triphosphate hydrolase superfamily
HA PCMH-like FAD binding 1.37± 0.25
HD PhoU-like superfamily 0.41± 0.20
HE Ubiquitin superfamily 1.24± 0.31
I HotDog superfamily 1.60± 0.24
I Creatinase/prolidase N-terminal domain superfamily 0.54± 0.20
IA PLC-like phosphodiesterases 0.53± 0.23
J Ribosomal protein S5 domain 2-like superfamily 0.32± 0.08
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J Transcription elongation factor G C-terminal 0.28± 0.11
J Helix-two-turns-helix superfamily 0.20± 0.17
J DALR superfamily 0.20± 0.12
K Peptidase clan SF 0.71± 0.20
L OB fold 0.45± 0.07
L PD-(D/E)XK nuclease superfamily 0.58± 0.23
L NUDIX superfamily 1.19± 0.21
L DNA breaking-rejoining enzyme superfamily 0.97± 0.25
L His-Me finger endonuclease superfamily 0.78± 0.28
L DNase I-like 0.75± 0.24
L GIY-YIG endonuclease superfamily 0.36± 0.22
L DNA/RNA ligase superfamily 0.55± 0.20
L HRDC-like superfamily 0.36± 0.16
LA Helix-turn-helix clan 1.64± 0.14
LA Periplasmic binding protein like 1.49± 0.38
LA
Fatty acid responsive transcription factor FadR,
1.98± 0.34
C-terminal domain
LA lambda integrase N-terminal domain 0.49± 0.22
LA MetJ/Arc repressor superfamily 0.56± 0.34
LA ParB-like superfamily 0.70± 0.26
LA IHF-like DNA-binding protein supewrfamily 0.39± 0.28
LB EPT/RTPC-like superfamily 0.33± 0.13
MA Ig-like fold superfamily (E-set) 1.49± 0.43
MA von Willebrand factor type A 1.17± 0.30
MA Pilus subunit 0.83± 0.41
MA PGBD superfamily 0.75± 0.33
MA Peptidase MD 0.48± 0.24
N Flagellar motor switch family 0.34± 0.30
O GroES-like superfamily 1.56± 0.28
O FKBP-like superfamily 0.62± 0.28
O Chaperone J-domain superfamily 0.45± 0.24
O Cyclophilin-like superfamily 0.74± 0.19
O HSP20-like chaperone superfamily 0.65± 0.24
OA Peptidase clan MA 0.97± 0.15
OA ClpP/Crotonase superfamily 1.06± 0.21
OA Peptidase clan MH/MC/MF 1.03± 0.19
OA Calcineurin-like phosphoesterase superfamily 1.00± 0.18
OA Peptidase clan CA 1.09± 0.24
OA LuxS/MPP-like metallohydrolase 0.48± 0.26
OA Peptidase clan PA 0.79± 0.26
OA MACRO domain superfamily 0.33± 0.18
OB PP2C-like superfamily 0.97± 0.34
P Ferritin-like Superfamily 1.05± 0.20
P Multicopper oxidase-like domain 0.93± 0.30
P SPFH superfamily 0.34± 0.23
P SufE/NifU superfamily 0.23± 0.16
Q Dimeric alpha/beta barrel superfamily 2.01± 0.29
R Bet V 1 like 1.50± 0.37
R Acetyl-decarboxylase like superfamily 1.06± 0.29
R Helical backbone metal receptor superfamily 0.81± 0.34
R GME superfamily 0.44± 0.21
RA 4Fe-4S ferredoxins 0.94± 0.35
RA Thioredoxin-like 1.16± 0.20
RA VOC superfamily 2.11± 0.32
RA Metallo-hydrolase/oxidoreductase superfamily 1.13± 0.17
RA ALDH-like superfamily 1.64± 0.25
RA 2Fe-2S iron-sulfur cluster binding domain 1.05± 0.26
RA Transthyretin superfamily 0.94± 0.53
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RA Flavoprotein 0.89± 0.27
RA Isocitrate/Isopropylmalate dehydrogenase-like superfamily 0.64± 0.17
RA
Formate/glycerate dehydrogenase
0.99± 0.19
catalytic domain-like superfamily
RA Ferredoxin / Ferric reductase-like NAD binding 1.02± 0.26
RA Dehydroquinate synthase-like superfamily 0.68± 0.29
RA FAD-linked oxidase C-terminal domain superfamily 1.21± 0.25
RA Acid phosphatase/Vanadium-dependent haloperoxidase 0.77± 0.24
RA LDH C-terminal domain-like superfamily 0.23± 0.25
RA FAD-linked oxidoreductase 0.52± 0.16
RB PLP dependent aminotransferase superfamily 1.22± 0.13
RB N-acetyltransferase like 1.70± 0.23
RB Glycosyl transferase clan GT-A 0.91± 0.20
RB Class-I Glutamine amidotransferase superfamily 0.99± 0.14
RB
Isomerase,CoA transferase &
1.04± 0.22
Translation initiation factor Superfamily
RB CoA-dependent acyltransferase superfamily 0.96± 0.39
RB Patatin/FabD/lysophospholipase-like superfamily 1.12± 0.26
RB Acyltransferase clan 0.67± 0.28
RC FAD/NAD(P)-binding Rossmann fold Superfamily 1.12± 0.08
RC Alpha/Beta hydrolase fold 1.54± 0.29
RC Actin-like ATPase Superfamily 0.75± 0.14
RC Thiolase-like Superfamily 1.22± 0.25
RC HAD superfamily 0.79± 0.19
RC Amidohydrolase superfamily 1.07± 0.17
RC Hexapeptide repeat superfamily 0.58± 0.19
RC ANL superfamily 1.91± 0.30
RC Serine beta-lactamase-like superfamily 0.90± 0.18
RC HD/PDEase superfamily 0.60± 0.27
RC NTN hydrolase superfamily 1.06± 0.17
RC Ribokinase-like superfamily 0.87± 0.20
RC Alkaline phosphatase-like 1.01± 0.30
RC Lysozyme-like superfamily 0.89± 0.26
RC LysM-like domain 0.53± 0.34
RC DHS-like NAD/FAD-binding domain 1.20± 0.18
RC Cytidine deaminase-like (CDA) superfamily 0.60± 0.14
RC Phospholipase D superfamily 0.55± 0.28
RC Histidine phosphatase superfamily 0.77± 0.26
RC Glycoside hydrolase/deacetylase superfamily 1.01± 0.25
RC Galactose Mutarotase-like superfamily 0.86± 0.31
RC SGNH hydrolase superfamily 0.91± 0.32
RC PFL-like glycyl radical enzyme superfamily 0.26± 0.31
RC Enolase N-terminal domain-like superfamily 1.06± 0.27
RC
Fumarylacetoacetate hydrolase,
1.34± 0.29
C-terminal domain, superfamily
RC L,D-transpeptidase catalytic domain 0.94± 0.30
RC Chorismate lyase/UTRA superfamily 0.82± 0.31
RC MoCo carrier protein-like superfamily 0.44± 0.16
RC Chelatase Superfamily 0.45± 0.24
RC
Fumarate reductase respiratory
0.31± 0.19
complex transmembrane subunits
RD Tetratrico peptide repeat superfamily 1.07± 0.44
RD Common phosphate binding-site TIM barrel superfamily 0.91± 0.11
RF Membrane and transport protein 1.01± 0.30
RF ABC transporter membrane domain clan 0.84± 0.26
RF NTF2-like superfamily 1.07± 0.36
S Zinc beta-ribbon 0.63± 0.20
S ACP-like superfamily 1.68± 0.41
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S SPOUT Methyltransferase Superfamily 0.31± 0.11
S PIN domain superfamily 0.87± 0.27
S STAS domain superfamily 1.17± 0.30
S YjgF-like superfamily 1.32± 0.24
S
Phenylalanine- and lysidine-tRNA
0.26± 0.17
synthetase domain superfamily
S YqeY-like superfamily 0.27± 0.14
S Maf/Ham1 superfamily 0.30± 0.17
SB AhpD-like superfamily 1.31± 0.28
ST Type III antifreeze and spore coat polysaccharide 0.62± 0.23
T His Kinase A (phospho-acceptor) domain 1.72± 0.19
T CheY-like superfamily 1.72± 0.23
T PAS domain clan 1.92± 0.44
T Nucleotide cyclase superfamily 1.63± 0.44
T GAF domain-like 2.15± 0.29
T PDZ domain-like peptide-binding superfamily 0.59± 0.18
T GlnB-like superfamily 0.71± 0.25
T Src homology-3 domain 0.25± 0.36
